| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 8739X25QI3 |
| InChI Key | AFJRDFWMXUECEW-LBPRGKRZSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C18H17Cl2FN4OS |
| Molecular Weight | 427.33 |
| AlogP | 3.89 |
| Hydrogen Bond Acceptor | 5.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 6.0 |
| Polar Surface Area | 72.94 |
| Molecular species | BASE |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 27.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Serine/threonine-protein kinase AKT inhibitor |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Kinase
Protein Kinase
AGC protein kinase group
AGC protein kinase AKT family
|
- | 0.08-16.9 | 2800 | 0.08-0.08 | - | |
|
Enzyme
Kinase
Protein Kinase
AGC protein kinase group
AGC protein kinase DMPK family
AGC protein kinase CRIK subfamily
|
- | - | 4258 | - | - | |
|
Enzyme
Kinase
Protein Kinase
AGC protein kinase group
AGC protein kinase DMPK family
AGC protein kinase ROCK subfamily
|
- | - | 2144 | - | - | |
|
Enzyme
Kinase
Protein Kinase
AGC protein kinase group
AGC protein kinase PKA family
|
- | - | 133 | - | - | |
|
Enzyme
Kinase
Protein Kinase
AGC protein kinase group
AGC protein kinase PKC family
AGC protein kinase PKC alpha subfamily
|
- | - | 21352 | - | - | |
|
Enzyme
Kinase
Protein Kinase
AGC protein kinase group
AGC protein kinase PKN family
|
- | - | 880 | - | - | |
|
Enzyme
Kinase
Protein Kinase
CAMK protein kinase group
CAMK protein kinase PKD family
|
- | - | 3911 | - | - | |
|
Enzyme
Transferase
|
- | - | - | - | -7.222-10.02 | |
|
Epigenetic regulator
Eraser
Histone deacetylase
HDAC class IIb
|
- | - | - | - | -7.69-2.11 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Breast Neoplasms | 3 | D001943 | ClinicalTrials |
| Histiocytosis, Langerhans-Cell | 2 | D006646 | ClinicalTrials |
| Ovarian Neoplasms | 2 | D010051 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
| Prostatic Neoplasms, Castration-Resistant | 1 | D064129 | ClinicalTrials |
| Multiple Myeloma | 1 | D009101 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEBI | 131168 |
| ChEMBL | CHEMBL2219422 |
| DrugBank | DB11648 |
| EPA CompTox | DTXSID60146711 |
| FDA SRS | 8739X25QI3 |
| Guide to Pharmacology | 7890 |
| PubChem | 46843057 |
| SureChEMBL | SCHEMBL187686 |
| ZINC | ZINC000043197674 |